Palexia Retard 200 mg tabletten met verlengde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h110730_smpc.pdf",
  "strength": null,
  "atc_label": "Tapentadol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg110730",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE 2208 (Release controlling polymer), K100M (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TAPENTADOLHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h110730.pdf",
  "authorised_at": "2012/03/16",
  "procedure_number": "DE/H/2020/007",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "110730",
  "additional_monitoring": "N"
}